Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by Health Canada
Imported GMP API across Canadian-US BorderEstablishes supply chain stability in Canada and large US pharmaceutical market
Stay updated with breaking news from Orion Lekos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Imported GMP API across Canadian-US BorderEstablishes supply chain stability in Canada and large US pharmaceutical market
/PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with clinically proven psilocybin...
/PRNewswire/ - "Apex files phase 2a Clinical Trial Application ("CTA") with Health Canada and announces Series A financing" Apex is pleased to announce its new...
VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ - 'Apex files phase 2a Clinical Trial Application ('CTA') with Health Canada and announces Series A finan...
/PRNewswire/ - "Apex files phase 2a Clinical Trial Application ("CTA") with Health Canada and announces Series A financing" Apex is pleased to announce its new...